X4 Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 11/14/2025 | 2.44 M | $8.33 M | 332.13% | 32.87% |
| BVF INC/IL | 11/14/2025 | 2.23 M | $7.64 M | 100.00% | 30.13% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 2.23 M | $7.62 M | 100.00% | 30.06% |
| ROSALIND ADVISORS, INC. | 11/13/2025 | 1.54 M | $5.28 M | 100.00% | 20.84% |
| DEEP TRACK CAPITAL, LP | 11/14/2025 | 1.12 M | $3.84 M | 100.00% | 15.14% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 11/13/2025 | 1.06 M | $3.61 M | 100.00% | 14.25% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 11/14/2025 | 933.33 K | $3.19 M | 300.00% | 12.59% |
| STEMPOINT CAPITAL LP | 11/14/2025 | 555.41 K | $1.90 M | 100.00% | 7.49% |
| VANGUARD GROUP INC | 11/07/2025 | 410.49 K | $1.40 M | 77.02% | 5.54% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2025 | 343.96 K | $1.18 M | 100.00% | 4.64% |
| PALE FIRE CAPITAL SE | 11/13/2025 | 180.85 K | $618.51 K | 201.16% | 2.44% |
| UBS GROUP AG | 11/13/2025 | 159.84 K | $546.64 K | 45.36% | 2.16% |
| PALUMBO WEALTH MANAGEMENT LLC | 11/10/2025 | 95.33 K | $326.02 K | 100.00% | 1.29% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 79.66 K | $272.47 K | 62.08% | 1.07% |
| BLACKROCK, INC. | 11/12/2025 | 61.93 K | $211.81 K | -65.44% | 0.84% |
| STATE STREET CORP | 11/14/2025 | 38.73 K | $132.47 K | 149.35% | 0.52% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 21.67 K | $74.10 K | 0.00% | 0.29% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 19.18 K | $65.59 K | 10.43% | 0.26% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 13.87 K | $47.43 K | 100.00% | 0.19% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 10.68 K | $36.52 K | 105.25% | 0.14% |
| GROUP ONE TRADING, L.P. | 11/12/2025 | 4.00 K | $13.67 K | 0.00% | 0.05% |
| MORGAN STANLEY | 11/14/2025 | 3.73 K | $12.75 K | -65.87% | 0.05% |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 11/14/2025 | 2.91 K | $9.97 K | 100.00% | 0.04% |
| ROYAL BANK OF CANADA | 11/14/2025 | 2.53 K | $9.00 K | -17.89% | 0.03% |
| PNC FINANCIAL SERVICES GROUP, INC. | 11/07/2025 | 1.76 K | $6.02 K | -1.90% | 0.02% |
| TD WATERHOUSE CANADA INC. | 11/03/2025 | 1.50 K | $5.37 K | 0.00% | 0.02% |
| RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2025 | 729 | $2.49 K | -92.51% | 0.01% |
| BLEICHROEDER LP | 11/14/2025 | 595 | $2.04 K | 0.00% | 0.01% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 554 | $1.90 K | -12.89% | 0.01% |
| RONALD BLUE TRUST, INC. | 10/16/2025 | 284 | $971 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 216 | $739 | 0.00% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 11/04/2025 | 38 | $131 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 11/07/2025 | 33 | $113 | 0.00% | 0.00% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 11/14/2025 | 33 | $113 | 100.00% | 0.00% |
| CITIGROUP INC | 11/10/2025 | 32 | $109 | -95.80% | 0.00% |
| HIGHMARK WEALTH MANAGEMENT LLC | 10/20/2025 | 6 | $21 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| FMR LLC | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| CLEARSTEAD ADVISORS, LLC | 11/10/2025 | 0 | $0 | -100.00% | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 10/23/2025 | 0 | $0 | -100.00% | 0.00% |
| FEDERATED HERMES, INC. | 11/03/2025 | 0 | $0 | -100.00% | 0.00% |
| UBS OCONNOR LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| GSA CAPITAL PARTNERS LLP | 11/07/2025 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| CWM, LLC | 10/15/2025 | 0 | $0 | -100.00% | 0.00% |
| SRS CAPITAL ADVISORS, INC. | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| SQUAREPOINT OPS LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
X4 Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 81 institutional investors and hedge funds held shares of X4 Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Bain Capital Life Sciences Investors, LLC: 2.44 M
BVF INC/IL: 2.23 M
Nantahala Capital Management, LLC: 2.23 M
Rosalind Advisors, Inc.: 1.54 M
Deep Track Capital, LP: 1.12 M
Stonepine Capital Management, LLC: 1.06 M
49.51% of X4 Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 25.64 M shares in the last 24 months. This purchase volume represents approximately $93.85 M in transactions.